RFL rafaelholdings.com: Company Value to Revenue Ratio

Rafael Holdings, Inc. (RFL) invests in biopharmaceuticals and real estate, facing valuation volatility within its medical subsidiaries and competition from private equity funds. The company's enterprise value-to-sales multiple helps identify abnormal price spikes, while 35827.59 indicates the level of this metric. Ownership of physical assets creates a stable barrier, although the biomed segment remains dependent on FDA regulatory decisions.
Rafael Holdings - analytical breakdowns and key metrics (RFL)

This indicator measures market capitalization and net debt relative to annual turnover, allowing for a valuation of the business regardless of leverage. By analyzing the ratio of enterprise value to revenue, an investor can see how Rafael Holdings, Inc. (RFL) expenditures on ESG certification and "green" property retrofitting impact the market premium applied to its operating income.